{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/entity/KRRO/timeline","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://api.ai-analytics.org/license","usage_info":"https://api.ai-analytics.org/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-22T11:59:13.170Z","methodology_url":"https://api.ai-analytics.org/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":4214,"canonical_name":"Korro Bio, Inc.","cik":"0001703647","uei":null,"lei":null,"duns":null,"ticker":"KRRO"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","open.payments","dol.form5500","hud.housing","irs.bmf"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":75,"clinical":1},"count":76,"timeline":[{"ts":"2026-09-11","kind":"sec.form144","reporter":"Atlas Venture Fund XI, L.P.","title":"Shareholder","shares":8450,"usd_value":110357,"security_title":"Common Stock","approx_sale_date":"2026-09-11","accession_number":"0001628280-26-061593","importance":40.0220714},{"ts":"2026-09-11","kind":"sec.form144","reporter":"Atlas Venture Opportunity Fund II, L.P.","title":"Shareholder","shares":1750,"usd_value":22855,"security_title":"Common Stock","approx_sale_date":"2026-09-11","accession_number":"0001628280-26-061592","importance":40.004571},{"ts":"2026-09-11","kind":"sec.form144","reporter":"Dolan Oliver","title":"Officer","shares":5,"usd_value":69,"security_title":"Common","approx_sale_date":"2026-09-11","accession_number":"0001959173-26-006900","importance":40.000013716},{"ts":"2026-09-11","kind":"sec.filing","form_type":"144","title":"144 — Korro Bio, Inc. — 2026-09-11","url_slug":"/sec/cik-0001703647/144/0001628280-26-061592","accession_number":"0001628280-26-061592","importance":30},{"ts":"2026-09-11","kind":"sec.filing","form_type":"144","title":"144 — Korro Bio, Inc. — 2026-09-11","url_slug":"/sec/cik-0001703647/144/0001959173-26-006900","accession_number":"0001959173-26-006900","importance":30},{"ts":"2026-08-11","kind":"sec.form144","reporter":"Atlas Venture Fund XI, L.P.","title":"Shareholder","shares":1775,"usd_value":23945,"security_title":"Common Stock","approx_sale_date":"2026-08-11","accession_number":"0001628280-26-055858","importance":40.00478895},{"ts":"2026-08-11","kind":"sec.form144","reporter":"Atlas Venture Opportunity Fund II, L.P.","title":"Shareholder","shares":368,"usd_value":4964,"security_title":"Common Stock","approx_sale_date":"2026-08-11","accession_number":"0001628280-26-055859","importance":40.000992864},{"ts":"2026-08-11","kind":"sec.filing","form_type":"144","title":"144 — Korro Bio, Inc. — 2026-08-11","url_slug":"/sec/cik-0001703647/144/0001628280-26-055858","accession_number":"0001628280-26-055858","importance":30},{"ts":"2026-08-11","kind":"sec.filing","form_type":"144","title":"144 — Korro Bio, Inc. — 2026-08-11","url_slug":"/sec/cik-0001703647/144/0001628280-26-055859","accession_number":"0001628280-26-055859","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — Korro Bio, Inc. — 2026-07-17","url_slug":"/sec/cik-0001703647/4/0001193125-26-306733","accession_number":"0001193125-26-306733","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — Korro Bio, Inc. — 2026-07-17","url_slug":"/sec/cik-0001703647/4/0001193125-26-306739","accession_number":"0001193125-26-306739","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — Korro Bio, Inc. — 2026-07-17","url_slug":"/sec/cik-0001703647/4/0001193125-26-306742","accession_number":"0001193125-26-306742","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — Korro Bio, Inc. — 2026-07-17","url_slug":"/sec/cik-0001703647/4/0001193125-26-306743","accession_number":"0001193125-26-306743","importance":30},{"ts":"2026-07-15","kind":"sec.insider.7500","reporter":"Vincent Loic A","title":"Chief Scientific Officer","shares":7500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-15","kind":"sec.insider.5500","reporter":"Dolan Oliver","title":"Senior Vice President, Finance","shares":5500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-15","kind":"sec.insider.6500","reporter":"Cerio Jeffrey","title":"General Counsel","shares":6500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-15","kind":"sec.insider.7500","reporter":"Chappell Todd","title":"Chief Operating Officer","shares":7500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-15","kind":"sec.insider.a","reporter":"Cerio Jeffrey","title":"General Counsel","shares":6500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-15","kind":"sec.insider.a","reporter":"Chappell Todd","title":"Chief Operating Officer","shares":7500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-15","kind":"sec.insider.a","reporter":"Dolan Oliver","title":"Senior Vice President, Finance","shares":5500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-15","kind":"sec.insider.a","reporter":"Vincent Loic A","title":"Chief Scientific Officer","shares":7500,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-06","kind":"sec.form144","reporter":"Atlas Venture Opportunity Fund II, L.P.","title":"Shareholder","shares":8506,"usd_value":119084,"security_title":"Common Stock","approx_sale_date":"2026-07-06","accession_number":"0001628280-26-047351","importance":40.0238168},{"ts":"2026-07-06","kind":"sec.form144","reporter":"Atlas Venture Fund XI, L.P.","title":"Shareholder","shares":817,"usd_value":11438,"security_title":"Common Stock","approx_sale_date":"2026-07-06","accession_number":"0001628280-26-047352","importance":40.0022876},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"FORMELA JEAN FRANCOIS","title":"","shares":8506,"price_per_share":13.96,"usd_value":118744,"security_title":"Common Stock","importance":35.11874376},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"FORMELA JEAN FRANCOIS","title":"","shares":817,"price_per_share":13.96,"usd_value":11405,"security_title":"Common Stock","importance":35.01140532},{"ts":"2026-07-06","kind":"sec.filing","form_type":"144","title":"144 — Korro Bio, Inc. — 2026-07-06","url_slug":"/sec/cik-0001703647/144/0001628280-26-047351","accession_number":"0001628280-26-047351","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"144","title":"144 — Korro Bio, Inc. — 2026-07-06","url_slug":"/sec/cik-0001703647/144/0001628280-26-047352","accession_number":"0001628280-26-047352","importance":30},{"ts":"2026-07-02","kind":"sec.form144","reporter":"Atlas Venture Fund XI, L.P.","title":"Shareholder","shares":85955,"usd_value":1173286,"security_title":"Common Stock","approx_sale_date":"2026-07-02","accession_number":"0001628280-26-046978","importance":40.23465715},{"ts":"2026-07-02","kind":"sec.form144","reporter":"Atlas Venture Opportunity Fund II, L.P.","title":"Shareholder","shares":14745,"usd_value":201269,"security_title":"Common Stock","approx_sale_date":"2026-07-02","accession_number":"0001628280-26-046980","importance":40.04025385},{"ts":"2026-07-02","kind":"sec.insider.s","reporter":"FORMELA JEAN FRANCOIS","title":"","shares":85955,"price_per_share":14.03,"usd_value":1205949,"security_title":"Common Stock","importance":36.205948649999996},{"ts":"2026-07-02","kind":"sec.insider.s","reporter":"FORMELA JEAN FRANCOIS","title":"","shares":14745,"price_per_share":14.03,"usd_value":206872,"security_title":"Common Stock","importance":35.20687235},{"ts":"2026-07-02","kind":"sec.filing","form_type":"144","title":"144 — Korro Bio, Inc. — 2026-07-02","url_slug":"/sec/cik-0001703647/144/0001628280-26-046978","accession_number":"0001628280-26-046978","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"144","title":"144 — Korro Bio, Inc. — 2026-07-02","url_slug":"/sec/cik-0001703647/144/0001628280-26-046980","accession_number":"0001628280-26-046980","importance":30},{"ts":"2026-06-24","kind":"sec.form144","reporter":"Atlas Venture Fund XI, L.P.","title":"Shareholder","shares":41345,"usd_value":566840,"security_title":"Common Stock","approx_sale_date":"2026-06-24","accession_number":"0001628280-26-045302","importance":40.11336799},{"ts":"2026-06-24","kind":"sec.form144","reporter":"Atlas Venture Opportunity Fund II, L.P.","title":"Shareholder","shares":7093,"usd_value":97245,"security_title":"Common Stock","approx_sale_date":"2026-06-24","accession_number":"0001628280-26-045301","importance":40.019449006},{"ts":"2026-06-24","kind":"sec.insider.s","reporter":"FORMELA JEAN FRANCOIS","title":"","shares":40679,"price_per_share":14.6,"usd_value":593913,"security_title":"Common Stock","importance":35.5939134},{"ts":"2026-06-24","kind":"sec.insider.s","reporter":"FORMELA JEAN FRANCOIS","title":"","shares":6979,"price_per_share":14.6,"usd_value":101893,"security_title":"Common Stock","importance":35.1018934},{"ts":"2026-06-24","kind":"sec.insider.s","reporter":"FORMELA JEAN FRANCOIS","title":"","shares":666,"price_per_share":14.98,"usd_value":9977,"security_title":"Common Stock","importance":35.00997668},{"ts":"2026-06-24","kind":"sec.insider.s","reporter":"FORMELA JEAN FRANCOIS","title":"","shares":114,"price_per_share":14.98,"usd_value":1708,"security_title":"Common Stock","importance":35.00170772},{"ts":"2026-06-24","kind":"sec.filing","form_type":"144","title":"144 — Korro Bio, Inc. — 2026-06-24","url_slug":"/sec/cik-0001703647/144/0001628280-26-045301","accession_number":"0001628280-26-045301","importance":30},{"ts":"2026-06-23","kind":"sec.form144","reporter":"Atlas Venture Fund XI, L.P.","title":"Shareholder","shares":101579,"usd_value":1411948,"security_title":"Common Stock","approx_sale_date":"2026-06-23","accession_number":"0001628280-26-044982","importance":40.282389620000004},{"ts":"2026-06-23","kind":"sec.insider.s","reporter":"FORMELA JEAN FRANCOIS","title":"","shares":101579,"price_per_share":14.25,"usd_value":1447501,"security_title":"Common Stock","importance":36.44750075},{"ts":"2026-06-23","kind":"sec.insider.s","reporter":"FORMELA JEAN FRANCOIS","title":"","shares":17426,"price_per_share":14.25,"usd_value":248321,"security_title":"Common Stock","importance":35.2483205},{"ts":"2026-06-23","kind":"sec.filing","form_type":"144","title":"144 — Korro Bio, Inc. — 2026-06-23","url_slug":"/sec/cik-0001703647/144/0001628280-26-044983","accession_number":"0001628280-26-044983","importance":30},{"ts":"2026-06-22","kind":"sec.form144","reporter":"Atlas Venture Fund XI, L.P.","title":"Shareholder","shares":21339,"usd_value":277194,"security_title":"Common Stock","approx_sale_date":"2026-06-22","accession_number":"0001628280-26-044738","importance":40.055438722},{"ts":"2026-06-22","kind":"sec.form144","reporter":"Atlas Venture Opportunity Fund II, L.P.","title":"Shareholder","shares":3661,"usd_value":47556,"security_title":"Common Stock","approx_sale_date":"2026-06-22","accession_number":"0001628280-26-044737","importance":40.009511278},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"FORMELA JEAN FRANCOIS","title":"","shares":3382,"price_per_share":13.95,"usd_value":47179,"security_title":"Common Stock","importance":35.0471789},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"FORMELA JEAN FRANCOIS","title":"","shares":580,"price_per_share":13.95,"usd_value":8091,"security_title":"Common Stock","importance":35.008091},{"ts":"2026-06-22","kind":"sec.filing","form_type":"144","title":"144 — Korro Bio, Inc. — 2026-06-22","url_slug":"/sec/cik-0001703647/144/0001628280-26-044737","accession_number":"0001628280-26-044737","importance":30},{"ts":"2026-06-17","kind":"sec.filing","form_type":"4","title":"4 — Korro Bio, Inc. — 2026-06-17","url_slug":"/sec/cik-0001703647/4/0001193125-26-274136","accession_number":"0001193125-26-274136","importance":30},{"ts":"2026-06-17","kind":"sec.filing","form_type":"4","title":"4 — Korro Bio, Inc. — 2026-06-17","url_slug":"/sec/cik-0001703647/4/0001193125-26-274143","accession_number":"0001193125-26-274143","importance":30},{"ts":"2026-06-17","kind":"sec.filing","form_type":"4","title":"4 — Korro Bio, Inc. — 2026-06-17","url_slug":"/sec/cik-0001703647/4/0001193125-26-274156","accession_number":"0001193125-26-274156","importance":30},{"ts":"2026-06-17","kind":"sec.filing","form_type":"4","title":"4 — Korro Bio, Inc. — 2026-06-17","url_slug":"/sec/cik-0001703647/4/0001193125-26-274171","accession_number":"0001193125-26-274171","importance":30},{"ts":"2026-06-16","kind":"sec.form144","reporter":"Cerio Jeffrey","title":"Officer","shares":6609,"usd_value":71576,"security_title":"Common","approx_sale_date":"2026-06-16","accession_number":"0001959173-26-004716","importance":40.014315226},{"ts":"2026-06-16","kind":"sec.form144","reporter":"Vincent Loic A","title":"Officer","shares":3418,"usd_value":37017,"security_title":"Common","approx_sale_date":"2026-06-16","accession_number":"0001959173-26-004717","importance":40.007403456},{"ts":"2026-06-16","kind":"sec.form144","reporter":"Dolan Oliver","title":"Officer","shares":3383,"usd_value":36638,"security_title":"Common","approx_sale_date":"2026-06-16","accession_number":"0001959173-26-004715","importance":40.007327646},{"ts":"2026-06-16","kind":"sec.form144","reporter":"Chappell Todd","title":"Officer","shares":3168,"usd_value":34310,"security_title":"Common","approx_sale_date":"2026-06-16","accession_number":"0001959173-26-004713","importance":40.006861952},{"ts":"2026-06-16","kind":"sec.insider.s","reporter":"Cerio Jeffrey","title":"General Counsel","shares":6609,"price_per_share":10.83,"usd_value":71575,"security_title":"Common Stock","importance":35.07157547},{"ts":"2026-06-16","kind":"sec.insider.s","reporter":"Vincent Loic A","title":"Chief Scientific Officer","shares":3418,"price_per_share":10.83,"usd_value":37017,"security_title":"Common Stock","importance":35.03701694},{"ts":"2026-06-16","kind":"sec.insider.s","reporter":"Dolan Oliver","title":"Senior Vice President, Finance","shares":3383,"price_per_share":10.83,"usd_value":36638,"security_title":"Common Stock","importance":35.03663789},{"ts":"2026-06-16","kind":"sec.insider.s","reporter":"Chappell Todd","title":"Chief Operating Officer","shares":3168,"price_per_share":10.83,"usd_value":34309,"security_title":"Common Stock","importance":35.03430944},{"ts":"2026-06-16","kind":"sec.filing","form_type":"144","title":"144 — Korro Bio, Inc. — 2026-06-16","url_slug":"/sec/cik-0001703647/144/0001959173-26-004713","accession_number":"0001959173-26-004713","importance":30},{"ts":"2026-06-16","kind":"sec.filing","form_type":"144","title":"144 — Korro Bio, Inc. — 2026-06-16","url_slug":"/sec/cik-0001703647/144/0001959173-26-004715","accession_number":"0001959173-26-004715","importance":30},{"ts":"2026-06-16","kind":"sec.filing","form_type":"144","title":"144 — Korro Bio, Inc. — 2026-06-16","url_slug":"/sec/cik-0001703647/144/0001959173-26-004716","accession_number":"0001959173-26-004716","importance":30},{"ts":"2026-06-16","kind":"sec.filing","form_type":"144","title":"144 — Korro Bio, Inc. — 2026-06-16","url_slug":"/sec/cik-0001703647/144/0001959173-26-004717","accession_number":"0001959173-26-004717","importance":30},{"ts":"2026-06-11","kind":"sec.filing","form_type":"8-K","title":"8-K — Korro Bio, Inc. — 2026-06-11","url_slug":"/sec/cik-0001703647/8-k/0001193125-26-267741","accession_number":"0001193125-26-267741","importance":35},{"ts":"2026-06-11","kind":"sec.filing","form_type":"4","title":"4 — Korro Bio, Inc. — 2026-06-11","url_slug":"/sec/cik-0001703647/4/0001193125-26-268001","accession_number":"0001193125-26-268001","importance":30},{"ts":"2026-06-11","kind":"sec.filing","form_type":"4","title":"4 — Korro Bio, Inc. — 2026-06-11","url_slug":"/sec/cik-0001703647/4/0001193125-26-268012","accession_number":"0001193125-26-268012","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — Korro Bio, Inc. — 2026-06-02","url_slug":"/sec/cik-0001703647/4/0001193125-26-252460","accession_number":"0001193125-26-252460","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — FORMELA JEAN FRANCOIS — 2026-06-01","url_slug":"/sec/cik-0001030575/4/0001030575-26-000002","accession_number":"0001030575-26-000002","importance":30},{"ts":"2026-05-29","kind":"sec.insider.s","reporter":"Aiyar Ram","title":"President and CEO","shares":15152,"price_per_share":12.98,"usd_value":196673,"security_title":"Common Stock","importance":35.19667296},{"ts":"2026-05-28","kind":"sec.insider.s","reporter":"FORMELA JEAN FRANCOIS","title":"","shares":2441,"price_per_share":13.95,"usd_value":34052,"security_title":"Common Stock","importance":35.03405195},{"ts":"2026-05-28","kind":"sec.insider.s","reporter":"FORMELA JEAN FRANCOIS","title":"","shares":419,"price_per_share":13.95,"usd_value":5845,"security_title":"Common Stock","importance":35.00584505},{"ts":"2026-05-19","kind":"sec.filing","form_type":"8-K","title":"8-K — Korro Bio, Inc. — 2026-05-19","url_slug":"/sec/cik-0001703647/8-k/0001193125-26-229610","accession_number":"0001193125-26-229610","importance":35},{"ts":"2026-05-12","kind":"sec.filing","form_type":"424B3","title":"424B3 — Korro Bio, Inc. — 2026-05-12","url_slug":"/sec/cik-0001703647/424b3/0001193125-26-219703","accession_number":"0001193125-26-219703","importance":30},{"ts":"2026-04-17","kind":"clinical.trial","reporter":"Korro Bio, Inc.","title":"A Phase 1/2a, Single- and Multiple-dose Escalation Study of KRRO-110","security_title":"PHASE1,PHASE2","status":"TERMINATED","accession_number":"NCT06677307","excerpt":"The study was terminated for business decision reasons.","importance":80}]}